Remeditex Ventures Llc - Net Worth and Insider Trading
Remeditex Ventures Llc Net Worth
The estimated net worth of Remeditex Ventures Llc is at least $208 Million dollars as of 2024-11-13. Remeditex Ventures Llc is the 10% Owner of Soliton Inc and owns about 9,214,277 shares of Soliton Inc (SOLY) stock worth over $208 Million. Remeditex Ventures Llc is also the 10% Owner of VYNE Therapeutics Inc and owns about 38,356 shares of VYNE Therapeutics Inc (VYNE) stock worth over $114,684. Details can be seen in Remeditex Ventures Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Remeditex Ventures Llc has not made any transactions after 2020-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Remeditex Ventures Llc
Remeditex Ventures Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Remeditex Ventures Llc owns 5 companies in total, including Soliton Inc (SOLY) , VYNE Therapeutics Inc (VYNE) , and Viridian Therapeutics Inc (VRDN) among others .
Click here to see the complete history of Remeditex Ventures Llc’s form 4 insider trades.
Insider Ownership Summary of Remeditex Ventures Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SOLY | Soliton Inc | 2020-06-30 | 10 percent owner |
| VYNE | VYNE Therapeutics Inc | 2018-01-25 | 10 percent owner |
| VRDN | Viridian Therapeutics Inc | 2017-02-13 | 10 percent owner |
 | | 2016-12-29 | 10 percent owner |
| | 2014-12-17 | 10 percent owner |
Remeditex Ventures Llc Latest Holdings Summary
Remeditex Ventures Llc currently owns a total of 2 stocks. Among these stocks, Remeditex Ventures Llc owns 9,214,277 shares of Soliton Inc (SOLY) as of June 30, 2020, with a value of $208 Million and a weighting of 99.94%. Remeditex Ventures Llc also owns 38,356 shares of VYNE Therapeutics Inc (VYNE) as of January 25, 2018, with a value of $114,684 and a weighting of 0.06%.
Latest Holdings of Remeditex Ventures Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SOLY | Soliton Inc | 2020-06-30 | 9,214,277 | 22.58 | 208,058,375 |
| VYNE | VYNE Therapeutics Inc | 2018-01-25 | 38,356 | 2.99 | 114,684 |
Holding Weightings of Remeditex Ventures Llc
Remeditex Ventures Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Remeditex Ventures Llc has made a total of 1 transactions in Soliton Inc (SOLY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Soliton Inc is the acquisition of 120,481 shares on June 30, 2020, which cost Remeditex Ventures Llc around $999,992.
According to the SEC Form 4 filings, Remeditex Ventures Llc has made a total of 0 transactions in VYNE Therapeutics Inc (VYNE) over the past 5 years. The most-recent trade in VYNE Therapeutics Inc is the acquisition of 1,389 shares on January 25, 2018, which cost Remeditex Ventures Llc around $2 Million.
Insider Trading History of Remeditex Ventures Llc
- 1
Remeditex Ventures Llc Trading Performance
GuruFocus tracks the stock performance after each of Remeditex Ventures Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Remeditex Ventures Llc is -37.13%. GuruFocus also compares Remeditex Ventures Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Remeditex Ventures Llc within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Remeditex Ventures Llc's insider trading performs compared to the benchmark.
Performance of Remeditex Ventures Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.55 | | | | | |
| Relative Return to S&P 500(%) | 2.81 | | | | | |
Remeditex Ventures Llc Ownership Network
Ownership Network List of Remeditex Ventures Llc
Ownership Network Relation of Remeditex Ventures Llc
Remeditex Ventures Llc Owned Company Details
What does Soliton Inc do?
Who are the key executives at Soliton Inc?
Remeditex Ventures Llc is the 10 percent owner of Soliton Inc. Other key executives at Soliton Inc include Chief Operating Officer Joe D Tanner , Chief Financial Officer Lori Bisson , and director & CEO & President Christopher Capelli .
Soliton Inc (SOLY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Soliton Inc (SOLY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soliton Inc (SOLY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Soliton Inc (SOLY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soliton Inc Insider Transactions
Remeditex Ventures Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Remeditex Ventures Llc. You might contact Remeditex Ventures Llc via mailing address: 2101 Cedar Springs Road, Suite 601, Dallas Tx 75201.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
